Literature DB >> 14694084

Sweet changes: glucose homeostasis can be altered by manipulating genes controlling hepatic glucose metabolism.

James J Collier1, Donald K Scott.   

Abstract

The liver is responsible for glucose synthesis in the fasting state, and glucose uptake, storage, and utilization in the fed state. A phenotypic switch, normally initiated by insulin or glucagon, controls the transition between the two states, which includes transcriptional alterations that regulate metabolic enzyme abundance for multiple metabolic pathways in a coordinated manner. A network of transcription factors, coactivators, and corepressors direct these changes, thus acting as transcriptional sensors of the nutritional status of an organism. The inability of the hepatocyte to undergo this metabolic reprogramming is characteristic of diabetes mellitus. Modulations that control the amount of individual metabolic enzymes or transcription factors can initiate the fasting-to-fed transition of the hepatocyte in an insulin-independent manner. Alternatively, overexpression of key regulators of metabolism can lock hepatocytes in the fasted state. These manipulations alter hepatic glucose flux, leading to either amelioration or induction of diabetes mellitus. These maneuvers reveal the complexity of the coordinated mechanisms used by the liver to alter its phenotype and provide evidence for the control strength of metabolic signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694084     DOI: 10.1210/me.2003-0357

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

1.  Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21.

Authors:  Holly A Cyphert; Xuemei Ge; Alison B Kohan; Lisa M Salati; Yanqiao Zhang; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

2.  The challenges for molecular nutrition research 2: quantification of the nutritional phenotype.

Authors:  Ben van Ommen; Jaap Keijer; Robert Kleemann; Ruan Elliott; Christian A Drevon; Harry McArdle; Mike Gibney; Michael Müller
Journal:  Genes Nutr       Date:  2008-06-25       Impact factor: 5.523

3.  c-Myc is required for the CHREBP-dependent activation of glucose-responsive genes.

Authors:  Pili Zhang; Mallikarjurna R Metukuri; Sharell M Bindom; Edward V Prochownik; Robert M O'Doherty; Donald K Scott
Journal:  Mol Endocrinol       Date:  2010-04-09

4.  Thiobenzothiazole-modified Hydrocortisones Display Anti-inflammatory Activity with Reduced Impact on Islet β-Cell Function.

Authors:  Susan J Burke; Amanda L May; Robert C Noland; Danhong Lu; Marcela Brissova; Alvin C Powers; Elizabeth M Sherrill; Michael D Karlstad; Shawn R Campagna; Jacqueline M Stephens; J Jason Collier
Journal:  J Biol Chem       Date:  2015-04-07       Impact factor: 5.157

5.  Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced β-cell damage in Wistar rat pancreas.

Authors:  G Dhanavathy
Journal:  J Endocrinol Invest       Date:  2015-03-15       Impact factor: 4.256

Review 6.  Pancreatic Islet Responses to Metabolic Trauma.

Authors:  Susan J Burke; Michael D Karlstad; J Jason Collier
Journal:  Shock       Date:  2016-09       Impact factor: 3.454

7.  Detailed molecular analysis of the induction of the L-PK gene by glucose.

Authors:  David T Eckert; Pili Zhang; J Jason Collier; Robert M O'Doherty; Donald K Scott
Journal:  Biochem Biophys Res Commun       Date:  2008-05-09       Impact factor: 3.575

8.  Hepatic IKKε expression is dispensable for high-fat feeding-induced increases in liver lipid content and alterations in glucose tolerance.

Authors:  J Jason Collier; Heidi M Batdorf; Tamra M Mendoza; David H Burk; Thomas M Martin; Jingying Zhang; Randall L Mynatt; Susan J Burke
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-10-29       Impact factor: 4.310

9.  Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle.

Authors:  Ksenija Slavic; Michael J Delves; Miguel Prudêncio; Arthur M Talman; Ursula Straschil; Elvira T Derbyshire; Zhengyao Xu; Robert E Sinden; Maria M Mota; Christophe Morin; Rita Tewari; Sanjeev Krishna; Henry M Staines
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

10.  Ameliorative property of Sesbania grandiflora on carbohydrate metabolic enzymes in the liver and kidney of streptozotocin-induced diabetic rats.

Authors:  Chandrabose Sureka; Veerayan Elango; Sameer Al-Ghamdi; Khaled K Aldossari; Mohammed Alsaidan; Ayman Geddawy; Mohamed A Abdelaziz; Abubucker Peer Mohideen; Thiyagarajan Ramesh
Journal:  Saudi J Biol Sci       Date:  2021-05-08       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.